Ignite Creation Date:
2025-12-24 @ 11:04 PM
Ignite Modification Date:
2026-01-03 @ 1:45 AM
Study NCT ID:
NCT02890069
Status:
COMPLETED
Last Update Posted:
2023-01-11
First Post:
2016-05-09
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study of PDR001 in Combination With LCL161, Everolimus or Panobinostat
Sponsor:
Novartis Pharmaceuticals
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-10-14
Start Date Type:
ACTUAL
Primary Completion Date:
2022-02-22
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-02-22
Completion Date Type:
ACTUAL
First Submit Date:
2016-05-09
First Submit QC Date:
None
Study First Post Date:
2016-09-07
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-01-10
Last Update Post Date:
2023-01-11
Last Update Post Date Type:
ACTUAL